Fairvalue-Calculator Fairvalue-Calculator
EN DE

Integrated BioPharma, Inc (INBP) Fair Value & Analysis

Consumer Defensive · US · Market cap $5.9M

Price$0.1800
Fair Value$0.5500
Upside+205.6%
Quality95/100
Evidence: High Range $0.4100 – $0.6800

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Integrated BioPharma, Inc (INBP) currently trades at $0.1800, while our model-based Fair Value estimate is $0.5500 — implying the stock looks roughly 205.6% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Open the full interactive analysis →

Similar stocks

Nestlé S.A (NESN) -36% Foshan Haitian Flavouring and Food Company (603288) -22% Nestlé India Limited (NESTLEIND) -74% Grupo Bimbo, S.A. (BIMBOA) -21% Uni-President Enterprises Corp (1216) -3% Britannia Industries Limited (BRITANNIA) -32%

Frequently asked questions

Is Integrated BioPharma, Inc (INBP) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.5500 versus a price of $0.1800 — about +206% (undervalued). Model-based estimate, not financial advice.
What is the fair value of INBP?
Our 21-model fair value for Integrated BioPharma, Inc is $0.5500 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.1800.
What is the quality score of INBP?
Integrated BioPharma, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.